Renal osteodystrophy based on bone histomorphometry: 20 Years of experience

Dialysis and Transplantation

Volumn 33, Issue 8, 2004, Pages 476-482

  Krpan, D ^a   Lajtman, Z ^a   Erceg, I ^a   Ivkosic, A ^a  

^a Croatian Academy of Medical Sciences   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE BIOPSY; BONE DISEASE; BONE REMODELING; BONE TURNOVER; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; METABOLIC DISORDER; MINERAL METABOLISM; MORPHOMETRICS; OSTEOMALACIA; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; UREMIA;

EID: 4043111411     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Ritz E, Drueke T, Merke J, Lucas PA. Genesis of bone disease in uremia. In: Bone and Mineral Research, Peck WA (ed.). Elsevier Science Publishers BV, 1988, pp 309-374.
2. Goodman WG, Coburn JW, Slatopolsky E, Salusky IB. Renal osteodystrophy in adults and children. In: Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism (3rd Ed.), Favus MJ (ed.). Lippincott-Raven, 1996, pp 341-362.
3. Malluche HH, Faugere MC. Mineralized bone histology of metabolic bone disease. In: Atlas of Mineralized Bone Histology, Malluche HH, Faugere MC (eds.). Karger, 1986, pp 50-118.
4. Sawaya BP, Malluche HH. Parathyroid hormone, vitamin D, and metabolic bone disease in dialysis patients. In: Clinical Dialysis (3rd Ed.), Nissenson AR, Fine RN, Gentile DE (eds.). Appleton and Lange, 1995, pp 744-777.
5. McCarthy EF, Frassica FJ (eds.). Pathology of Bone and Joint Disorders with Clinical and Radiographic Correlation. W.B. Saunders Co., 1998, pp 1-371.
6. Pecovnik Balon B, Bren A. Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy. Clin Nephrol 2000; 54(6):463-469.
7. Juppner H. Role of parathyroid hormone-related peptide in skeletal development. In: Nutrition and Bone Development, Bonjour JP, Tsang RC (eds.). Lippincott-Raven, 1999, pp 19-31.
8. Jahle PM, Ostertag A, Schulten K, Schulz W, Jehle RD, Stracke S, Fiedler R, Deuber HJ, Keller F, Bohem BO, Baylink DJ, Mohan S. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int 2000; 57:423-436.
9. Caverzasio J, Palmer G, Bonjour JP. Phosphate, osteogenic factors, and bone growth. In: Nutrition and Bone Development, Bonjour JP, Tsang RC (eds.). Lippincott-Raven, 1999, pp 47-59.
10. Eisman JA. Genetic determinants of peak bone mass. In: Nutrition and Bone Development, Bonjour JP, Tsang RC (eds.). Lippincott-Raven, 1999, pp 165-177.
11. Pecovnik Balon B, Krpan D. Patients with analgesic nephropathy on chronic hemodialysis have a high incidence of severe secondary hyperparathyroidism. Clin Nephrol 1998; 6:347-351.
12. Krpan D. Histomorfometrijske znacajke kosti bolesnika na kronicnoj dijalizi. Medicinski fakultet Sveucilista u Zagrebu, 1991 (PhD thesis).
13. Recker RR. Bone biopsy and histomorphometry in clinical practice. In: Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism (3rd Ed.), Favus MJ (ed.). Lippincott-Raven, 1996, pp 165-168.
14. Malluche HH, Faugere MC. The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Nephrol 1994; 1631-1642.
15. Krpan D, Milutinovic S, Nikolic V, Tomicic D, Lajtman Z, Prot F. Oxalosis associated with aluminum bone disease: A new type of mixed renal osteodystrophy. Nephron 1994; 66:99-101.
16. Changsirikulchai S, Domrongkitchaiporn S, Sirikulchayanonta V, Ongphiphadhanakul B, Kunkitti N, Stitchantrakul W, Radienahamed P. Renal osteodystrophy in Ramathibodi Hospital: Histomorphometry and clinical correlation. J Med Assoc Thai 2000; 83(10):1223-1232.
17. Fournier A, Boudailliez B, Westeel PF, Meuniner PJ, Idrissi A, Belbrik S, Hocine C, Marie A, Cohen-Solal ME. Prevention of secondary hyperparathyroidism in chronic renal failure before dialysis. Contrib Nephrol 1989; 71:64-80.